KBRA Releases Surveillance Report for Old Second Bancorp, Inc.
NEW YORK–(BUSINESS WIRE)–#KBRA–On July 27, 2023, KBRA affirmed the senior unsecured debt rating of BBB,…
NEW YORK–(BUSINESS WIRE)–#KBRA–On July 27, 2023, KBRA affirmed the senior unsecured debt rating of BBB,…
Company’s renewed success centers on increased focus on customer and partner engagement SUNNYVALE, Calif.–(BUSINESS WIRE)–Nexsan®,…
DALLAS–(BUSINESS WIRE)–Ryan, a leading global tax services and software provider, recently announced the promotions of…
TUALATIN-PORTLAND, OR – August 2, 2023 – iGrafx, a leading provider in digital business transformation…
Leading Infrastructure and Market Data Provider Confirms Position as Microsoft Solutions Partner for Data &…
Ascent Cloud customers will be able to plan, execute, and grow more effectively with these…
More than 100 independent Financial Professionals have joined Avantax this year through the second quarter…
New York, New York–(Newsfile Corp. – August 15, 2023) – The prestigious Miss Chinese Beauty…
Washington, D.C., Aug 15, 2023 – (ACN Newswire) – The stage is set for a…
STATE COLLEGE, Pa.–(BUSINESS WIRE)–#Agriculture—Phospholutions Inc., a pioneer in sustainable fertilizer technology, has announced an additional…
LAS VEGAS–(BUSINESS WIRE)–$AGREE #AGREE—Ault Alliance, Inc. (NYSE American: AULT), a diversified holding company (“Ault Alliance”…
Anonos highlighted as a leading vendor in seven Gartner 2023 Hype Cycle reports for its…
Leading business advisory firm among fastest-growing private U.S. companies with three-year revenue growth of 110%…
Orlando, FL, Aug. 15, 2023 (GLOBE NEWSWIRE) — Immune Therapeutics, Inc. d/b/a Biostax Corp. (OTC…
Orlando, FL, Aug. 15, 2023 (GLOBE NEWSWIRE) — Immune Therapeutics, Inc. d/b/a Biostax Corp. (OTC…
FORT LEE, N.J., Aug. 15, 2023 (GLOBE NEWSWIRE) — Elevar Therapeutics, Inc., a majority-owned subsidiary…
FORT LEE, N.J., Aug. 15, 2023 (GLOBE NEWSWIRE) — Elevar Therapeutics, Inc., a majority-owned subsidiary…
LONDON and NEW YORK, Aug. 15, 2023 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: OKYO),…
LONDON and NEW YORK, Aug. 15, 2023 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: OKYO),…
Company Hopes in 30 Days to Begin Making Its Drug Candidate Available to Help Patients…